Syndax Pharmaceuticals Inc Ratios

Ratios Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 96.51%
EBT Margin -3,497.13%-3,509.02%-2,871.58%-4,873.70%-3,689.39%-4,808.11%17.70%4,750.46%100,480.29%-1,345.06%
EBIT Margin -3,271.61%-3,587.38%-2,938.99%-5,001.71%-3,792.95%-4,708.17%18.77%4,837.65%110,554.81%-1,434.43%
EBITDA Margin -3,271.61%-3,587.38%-2,938.99%-5,001.71%-3,792.95%-4,708.17%18.77%4,837.65%110,554.81%-1,434.43%
Operating Margin -3,271.61%-3,587.38%-2,938.99%-5,001.71%-3,792.95%-4,708.17%18.77%4,837.65%110,554.81%-1,434.43%
Net Margin -3,497.13%-3,509.02%-2,871.58%-4,873.70%-3,689.39%-4,808.11%17.70%4,760.54%100,653.85%-1,346.11%
FCF Margin -395.06%-2,903.11%-2,251.19%-4,529.86%-3,336.32%-4,697.43%20.76%4,261.24%77,212.02%-1,160.91%
Efficiency
Inventory Average 0.34M0.34M0.16M0.13M0.11M
Assets Average 99.46M123.10M110.56M73.73M182.07M375.13M473.45M555.06M668.85M
Equity Average -84.14M94.23M78.68M42.32M141.89M330.28M437.91M510.82M421.16M
Invested Capital -252.28M84.14M104.32M53.05M31.60M254.47M408.56M467.45M554.20M300.24M
Asset Utilization Ratio 0.010.020.010.020.010.37-0.010.000.04
Leverage & Solvency
Interest Coverage Ratio -30.3013.81-48.38-0.00M-68.91
Debt to Equity 0.000.080.051.19
Debt Ratio 0.000.070.040.47
Equity Ratio -2.810.770.760.630.500.840.910.940.900.40
Times Interest Earned -30.3013.81-48.38-0.00M-68.91
Valuation
Enterprise Value -86.49M25.12M83.46M29.39M178.40M793.46M859.00M1,259.22M934.24M555.54M
Market Capitalization 130.45M213.66M110.52M238.29M908.93M1,081.19M1,735.02M1,504.93M1,128.43M
Return Ratios
Return on Sales -34.97%-35.09%-28.72%-48.74%-36.89%-48.08%0.18%47.50%-13.45%
Return on Capital Employed -0.49%-0.58%-0.80%-1.04%-0.44%0.07%-0.34%-0.46%-0.60%
Return on Assets -0.43%-0.49%-0.67%-0.76%-0.40%0.07%-0.31%-0.38%-0.48%
Return on Equity 0.51%-0.64%-0.94%-1.32%-0.51%0.07%-0.34%-0.41%-0.76%